Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts’ opinion. The compromise between EBM and possibilities in healthcare

Detalles Bibliográficos
Autores principales: Banach, Maciej, Kaźmierczak, Jarosław, Mitkowski, Przemysław, Wita, Krystian, Broncel, Marlena, Gąsior, Mariusz, Gierlotka, Marek, Gil, Robert, Jankowski, Piotr, Niewada, Maciej, Witkowski, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Editor’s CHOICE/OPINION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103399/
https://www.ncbi.nlm.nih.gov/pubmed/35591826
http://dx.doi.org/10.5114/aoms/147435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103399/
https://www.ncbi.nlm.nih.gov/pubmed/35591826
http://dx.doi.org/10.5114/aoms/147435

Ejemplares similares